COVID-19 Update - This is to inform you that the Government of India has announced a complete lockdown in India 22nd March 2020 to 14th April 2020. As a result, our offices will now be closed till 14th April 2020 and all our employees will be working from home. Office telephones will not be answered, and therefore you are requested to direct all your queries related to manuscript submission, review process, publication etc. at below mentioned details.,, Mob. 8826373757, 8826859373, 9910947804

Article view: 19

Article download: 9

Indian Journal of Clinical and Experimental Ophthalmology

Topical 1% voriconazole ophthalmic solution in the treatment of mycotic corneal ulcer

Full Text PDF Share on Facebook Share on Twitter

Research Article

Author Details : Sunil Kumar, Shreya Chaurasia*, Sheezan Imam

Volume : 6, Issue : 1, Year : 2020

Article Page : 57-60

Suggest article by email


Fungal keratitis is a major cause of ocular morbidity and unilateral blindness 1worldwide. In India
it contributes to 50% of culture positive cases. 2 Despite the emergence of many new drugs, a cure
remains difficult in many cases. Compared to anti- bacterial, anti-fungal have lower efficacy, lower tissue
penetration and indolent nature of the infection.
This article aims to study effectiveness of topical 1% voriconazole as first line of treatment in 50 patients
of mycotic corneal ulcer.

Keywords: Fungal corneal ulcer, Voriconazole.

Doi : 10.18231/j.ijceo.2020.012

How to cite : Kumar S , Chaurasia S, Imam S, Topical 1% voriconazole ophthalmic solution in the treatment of mycotic corneal ulcer. Indian J Clin Exp Ophthalmol 2020;6(1):57-60

Copyright © 2020 by author(s) and Indian J Clin Exp Ophthalmol. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0) (